AMRX FY 2019 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMRXAmneal Pharmaceuticals, Inc.

$4B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.6B-2.2% YoY

Gross Profit

$353M21.7% margin

Operating Income

-$249M-15.3% margin

Net Income

-$362M-22.3% margin

EPS (Diluted)

$-4.57

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$96M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$3.3B

Stockholders' Equity

$232M

Cash & Equivalents

$151M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.7B	-2.2%
Gross Profit	$353M	$716M	-50.7%
Operating Income	-$249M	-$20M	-1164.1%
Net Income	-$362M	-$170M	-113.2%